ADVISORY AGREEMENTAdvisory Agreement • January 5th, 2023 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 5th, 2023 Company Industry JurisdictionThis ADVISORY AGREEMENT (this “Agreement”) is made and entered into as of January 1, 2023 (the “Effective Date”), by and between Relmada Therapeutics, Inc., a Nevada corporation (the “Company”), and Paul Kelly (the “Advisor”).